In this IIL accident webinar, Tanya Patel and Tom Daniels will provide an insight into the niche area of clinical trials insurance and an overview of the challenges, opportunities and innovation in this space that have come hand-in-hand with the Covid-19 pandemic.

Description

Throughout the current pandemic, clinical trials have been thrust into the spotlight as the world eagerly awaits new vaccines and therapeutics that are effective against this novel virus.

In this session, the speakers will provide an introduction to clinical trials insurance and risk factors and hope to provide an insight into the terminology we’ve all be seeing in the media but not necessarily understood.

Through a selection of case studies, the speakers will look at the challenges and considerations the pandemic has brought when reviewing clinical trials risks, and also have a look at some of the innovative Covid-19 related clinical trial activity currently underway.

Gain an insight into

• Clinical trial terminology and risk factors
• Clinical trials challenges and considerations during a pandemic
• Some of the innovative Covid-19 related clinical trial activity currently underway

Speakers

• Tanya Patel, Life Science Practice Underwriter, HDI Global SE – UK
• Tom Daniels, Life Science Practice Leader, HDI Global SE – UK